Personalized medicine: current status and prospects

Home/2019, Vol. 7, No. 1/Personalized medicine: current status and prospects

Cell and Organ Transplantology. 2019; 7(1):in press.
DOI: 10.22494/cot.v7i1.96

Personalized medicine: current status and prospects

Nasadyuk C. M., Sklyarov O. Ya.
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Abstract
The article presents modern view at the personalized (precision) medicine and discusses the role of genome, glycobiome, microbiome studies in the selection of individualized treatment. Actual data on the options of target immunotherapy of cancer are presented. Up-to-date feasibility of personalized therapy and perspectives for its development are considered.

Key words: personalized medicine; precision medicine; genome; glycobiome; microbiome

Full Text PDF (eng) Full Text PDF (ua)

1. Almeida A, Kolarich D. The promise of protein glycosylation for personalized medicine. Biochim Biophys Acta. 2016; 1860(8):1583-1595.
https://doi.org/10.1016/j.bbagen.2016.03.012
PMid:26987810
2. Miura Y, Endo T. Glycomics and glycoproteomics focused on aging and age-related diseases-Glycans as a potential biomarker for physiological alterations. Biochim Biophys Acta. 2016; 1860(8):1608-1614.
https://doi.org/10.1016/j.bbagen.2016.01.013
PMid:26801879
3. Baxendale S, van Eeden F, Wilkinson R. The Power of Zebrafish in Personalized Medicine. Adv Exp Med Biol. 2017; 1007:179-197.
https://doi.org/10.1007/978-3-319-60733-7_10
PMid:28840558
4. Balfour-Lynn IM. Personalized medicine in cystic fibrosis is unaffordable. Paediatr Respir Rev. 2014; 15(1):2-5.
https://doi.org/10.1016/j.prrv.2014.04.003
PMid:24832698
5. Savard J. Personalized medicine: a critique on the future of health care. J Bioeth Inq.2013; 10(2):197-203.
https://doi.org/10.1007/s11673-013-9429-8
PMid:23515958
6. Brittain HK, Scott R, Thomas E. The rise of the genome and personalized medicine. Clinical Medicine. 2017; 17(6): 545-551.
https://doi.org/10.7861/clinmedicine.17-6-545
PMid:29196356 PMCid:PMC6297695
7. Dalbeth N, Stamp LK, Merriman TR. The genetics of gout: towards personalized medicine? BMC Medicine. 2017; 15:108.
https://doi.org/10.1186/s12916-017-0878-5
PMid:28566086 PMCid:PMC5452604
8. Hov JE, Trøseid M. Personalized medicine targeting the gut microbiota? Tidsskr Nor Laegeforen. 2015; 135(7):624.
https://doi.org/10.4045/tidsskr.14.1431
PMid:25899345
9. Day S, Coombes RC, McGrath-Lone L, et al. Stratified, precision or personalized medicine? Cancer services in the ‘real world’ of a London hospital. Sociol Health Illn. 2017; 39(1):143-158.
https://doi.org/10.1111/1467-9566.12457
PMid:27460935
10. Arjmand B, Goodarzi P, Mohamadi-Jahani F. Personalized Regenerative Medicine. Acta Medica Iranica. 2017; 55(3):144-149.
11. Krasnewich D. Human glycosylation disorders. Cancer Biomarkers. 2014; 14:3-16.
https://doi.org/10.3233/CBM-130374
PMid:24643038
12. Schnaar RL. Glycobiology simplified: diverse roles of glycan recognition in inflammation. Journal of Leukocyte Biology. 2016; 99(6):825-838.
https://doi.org/10.1189/jlb.3RI0116-021R
PMid:27004978 PMCid:PMC4952015
13. Adkar SS, Brunger GM, Willard VP, et al. Genome Engineering for Personalized Arthritis Therapeutics. Trends Mol Med. 2017; 23(10): 917-931.
https://doi.org/10.1016/j.molmed.2017.08.002
PMid:28887050 PMCid:PMC5657581
14. Kavanaugh D, O’Callaghan J, Kilcoyne M. The intestinal glycome and its modulation by diet and nutrition. Nutrition Reviews. 2015; 73(6):359-375.
https://doi.org/10.1093/nutrit/nuu019
PMid:26011911
15. Zenner HP. Individual Biomarkers Using Molecular Personalized Medicine Approaches. ORL J Otorhinolaryngol Relat Spec. 2017; 79(1-2):7-13.
https://doi.org/10.1159/000455811
PMid:28231575
16. Shukla SK, Murali NS, Brilliant MH. Personalized Medicine Going Precise: From Genomics to Microbiomics. Trends Mol Med. 2015; 21(8):461-462.
https://doi.org/10.1016/j.molmed.2015.06.002
PMid:26129865 PMCid:PMC4530069
17. Hartmann J. Clinical development of CAR T cells – challenges and opportunities in translating innovative treatment concepts. EMBO Mol Med. 2017; 9(9):1183-1197.
https://doi.org/10.15252/emmm.201607485
PMid:28765140 PMCid:PMC5582407
18. Ren J, Zhao Y. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9. Protein Cell. 2017; 8(9):634-643.
https://doi.org/10.1007/s13238-017-0410-x
PMid:28434148 PMCid:PMC5563282
19. https://clinicaltrials.gov/
20. Jackson SE, Chester JD. Personalized cancer medicine. Int J Cancer. 2015; 137:262-266.
https://doi.org/10.1002/ijc.28940
PMid:24789362
21. Marotz CA, Zarrinpar A. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. Yale J Biol Med. 2016; 89(3):383-388.
22. Gilbert B, Schrenzel J. Fecal microbiota transplantation: current status and prospect. Rev Med Suisse. 2019; 15(650):976-983.
23. Chang CS, Ruan JW, Kao CY. An overview of microbiome based strategies on anti-obesity. Kaohsiung J Med Sci. 2019; 35(1):7-16.
https://doi.org/10.1002/kjm2.12010
PMid:30844145
24. Tavassoly I, Hu Y, Zhao S, et al. Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses. Mol Oncol. 2019. DOI: 10.1002/1878-0261.12521. [Epub ahead of print].
https://doi.org/10.1002/1878-0261.12521
PMid:31116490
25. El-Deiry WS, Goldberg RM, Lenz HJ, et al. The current state of molecular testing in the treatment of patients with solid tumors. CA Cancer J Clin. 2019. DOI: 10.3322/caac.21560. [Epub ahead of print].
https://doi.org/10.3322/caac.21560
PMid:31116423

Nasadyuk C, Sklyarov O. Personalized medicine: current status and prospects. Cell and Organ Transplantology. 2019; 7(1):63-65. doi:10.22494/cot.v7i1.96

Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.